Quanta Dialysis Technologies

临床试验

计划入组 46 人 · 首次发布于 2021 年 7 月 26 日

终止

NCT00576524

Application of Impedance Threshold Device Technologies to Treat and Prevent Hypotension During Dialysis

计划入组 2 人 · 首次发布于 2007 年 12 月 19 日

进行中（未招募）

NCT06827041

Use of Phage Therapy for Treatment of a Periprosthetic Joint Infection

计划入组 1 人 · 首次发布于 2025 年 2 月 14 日

药物

查看全部 213 →

Acute myeloid leukaemia vaccine (AVAX Technologies)

Small Molecule

Approved

Icodextrin(Extraneal)

生产企业：Baxter healthcare corp

FGF-2 agonist (Buck Institute/Neurobiological Technologies)

机构

查看全部 358 →

DIALYSIS CLINIC INC

United States

Renex Dialysis Clinic Maplewood, Inc.

United States

New York Dialysis Services, Inc.

United States

资讯

查看全部 5060 →

去年

Quanta Dialysis System Receives FDA Clearance for Home Hemodialysis

去年

Quanta's Home Hemodialysis System Receives FDA Clearance, Expanding Access to High-Flow Dialysis

2年前

临床试验

Quanta Home Run Trial

Application of Impedance Threshold Device Technologies to Treat and Prevent Hypotension During Dialysis

Use of Phage Therapy for Treatment of a Periprosthetic Joint Infection

药物

Acute myeloid leukaemia vaccine (AVAX Technologies)

Icodextrin(Extraneal)

FGF-2 agonist (Buck Institute/Neurobiological Technologies)

机构

DIALYSIS CLINIC INC

Renex Dialysis Clinic Maplewood, Inc.

New York Dialysis Services, Inc.

资讯

Quanta Dialysis System Receives FDA Clearance for Home Hemodialysis

Quanta's Home Hemodialysis System Receives FDA Clearance, Expanding Access to High-Flow Dialysis

Quanta Therapeutics' QTX3034 Receives FDA IND Clearance for KRASG12D-Mutated Solid Tumors